What Researchers Did
This review article summarized the current evidence for hyperbaric oxygen therapy (HBO) in treating diabetic foot ulcers, focusing on findings from two randomized double-blind trials.
What They Found
Two randomized double-blind trials provided stronger evidence supporting adjunctive hyperbaric oxygen therapy (HBO) for selected patients with nonhealing diabetic foot ulcers. While some health economic studies suggested potential cost-effectiveness, these were limited by insufficient primary clinical data.
What This Means for Canadian Patients
Canadian patients with nonhealing diabetic foot ulcers might consider discussing hyperbaric oxygen therapy (HBO) as an adjunctive treatment option with their healthcare providers. However, further research is needed to identify which patients benefit most and optimal treatment protocols.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or by Canadian researchers.
Study Limitations
The review highlights that health economic studies on HBO are limited by deficient primary clinical data, and robust criteria are still needed for patient selection and treatment protocols.